These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2342989)

  • 1. Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex.
    Ikegami H; Prasad C
    Peptides; 1990; 11(1):145-8. PubMed ID: 2342989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cyclo(His-Pro) act like amphetamine?
    Mizuma H; Shimizu I; Hilton C; Prasad C
    Life Sci; 1994; 54(21):1625-33. PubMed ID: 8196482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo (His-Pro), d-amphetamine and striatal dopamine: a microdialysis study.
    Levy A; Stillman MJ; Rauch TM
    Brain Res Bull; 1991 Jul; 27(1):129-31. PubMed ID: 1933425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging.
    Shimizu I; Prasad C
    J Neurochem; 1991 Feb; 56(2):575-9. PubMed ID: 1988557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine.
    Meiergerd SM; Schenk JO
    J Neurochem; 1994 Nov; 63(5):1683-92. PubMed ID: 7931324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.
    Dersch CM; Akunne HC; Partilla JS; Char GU; de Costa BR; Rice KC; Carroll FI; Rothman RB
    Neurochem Res; 1994 Feb; 19(2):201-8. PubMed ID: 8183430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity stereospecific binding of [3H] cocaine in striatum and its relationship to the dopamine transporter.
    Calligaro DO; Eldefrawi ME
    Membr Biochem; 1987-1988; 7(2):87-106. PubMed ID: 3454391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two diketopiperazines, cyclo (His-Pro) and cyclo (Asp-Phe), on striatal dopamine: a microdialysis study.
    Kaakkola S; Wurtman RJ
    Brain Res Bull; 1993; 32(6):667-72. PubMed ID: 7693310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus.
    Jikihara H; Ikegami H; Koike K; Wada K; Morishige K; Kurachi H; Hirota K; Miyake A; Tanizawa O
    Endocrinology; 1993 Mar; 132(3):953-8. PubMed ID: 7679984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
    Reith ME; Selmeci G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ; Marshall JF
    Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide-dopamine interactions. IV. Effect of thyrotropin-releasing hormone on striatal dopaminergic neurons.
    Ikegami H; Spahn SA; Prasad C
    Peptides; 1989; 10(3):681-5. PubMed ID: 2528727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
    Kula NS; Baldessarini RJ
    Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.